• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子-β诱导的T细胞功能抑制。不同表型和功能的T细胞的敏感性差异及其与荷瘤状态下免疫抑制的相关性。

Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state.

作者信息

Tada T, Ohzeki S, Utsumi K, Takiuchi H, Muramatsu M, Li X F, Shimizu J, Fujiwara H, Hamaoka T

机构信息

Biomedical Research Center, Osaka University Medical School, Japan.

出版信息

J Immunol. 1991 Feb 1;146(3):1077-82.

PMID:1671050
Abstract

The present study investigates the nature of humoral component(s) generated in tumor-bearing hosts to induce immune dysfunction of T cells. Cell-free ascitic fluid and culture supernatant (SN) were obtained from the ascites and cultures allowing MH134 hepatoma cells to grow. These ascites and SN samples were tested for their abilities to influence the generation of CTL responses to TNP and alloantigens. The generation of the anti-TNP CTL responses that require self H-2-restricted CD4+ Th cells was markedly suppressed by addition of the ascites or SN under conditions in which these samples did not inhibit anti-allo CTL responses capable of using alternate pathways of allo-restricted CD4+ and CD8+ Th. The activation of CD8+ CTL precursors and CTL activity were also resistant to the ascites or SN. The ascites- or SN-induced suppressive effect to which CD4+ Th were most susceptible was found to be mediated by transforming growth factor-beta (TGF-beta) activity, because: 1) the TGF-beta activity was detected in the MH134 ascites and culture SN; 2) the suppression of CD4+ Th function required for anti-TNP CTL responses was almost completely prevented by addition of anti-TGF-beta antibody to cultures and; 3) rTGF-beta also induced similar patterns of immunosuppression to those observed by ascites or SN. These results indicate that TGF-beta produced by tumor cells induces deleterious effects on T cell, especially on the CD4+ Th subset, and provide an explanation for the molecular mechanism underlying the previously observed CD4+ Th-selective suppression in the tumor-bearing state.

摘要

本研究调查了荷瘤宿主中产生的体液成分的性质,这些成分可诱导T细胞免疫功能障碍。从允许MH134肝癌细胞生长的腹水和培养物中获取无细胞腹水和培养上清液(SN)。检测这些腹水和SN样品影响对TNP和同种异体抗原的CTL反应产生的能力。在这些样品不抑制能够使用同种异体限制的CD4+和CD8+Th细胞的替代途径的抗同种异体CTL反应的条件下,添加腹水或SN可显著抑制需要自身H-2限制的CD4+Th细胞的抗TNP CTL反应的产生。CD8+CTL前体的激活和CTL活性也对腹水或SN具有抗性。发现CD4+Th最易受腹水或SN诱导的抑制作用是由转化生长因子-β(TGF-β)活性介导的,因为:1)在MH134腹水和培养SN中检测到TGF-β活性;2)通过向培养物中添加抗TGF-β抗体,几乎完全阻止了抗TNP CTL反应所需的CD4+Th功能的抑制;3)重组TGF-β也诱导了与腹水或SN观察到的类似的免疫抑制模式。这些结果表明,肿瘤细胞产生的TGF-β对T细胞,尤其是对CD4+Th亚群产生有害影响,并为先前观察到的荷瘤状态下CD4+Th选择性抑制的分子机制提供了解释。

相似文献

1
Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state.转化生长因子-β诱导的T细胞功能抑制。不同表型和功能的T细胞的敏感性差异及其与荷瘤状态下免疫抑制的相关性。
J Immunol. 1991 Feb 1;146(3):1077-82.
2
Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.转化生长因子β1对肿瘤特异性细胞毒性T淋巴细胞反应的抑制作用。
Cancer Res. 1992 Mar 15;52(6):1386-92.
3
Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses.参与抗同种异体I类H-2免疫反应的CD4+ T细胞的异质性。主要增殖细胞与辅助细胞毒性T细胞反应的辅助细胞之间的功能区分。
J Immunol. 1991 Apr 15;146(8):2513-21.
4
Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.肿瘤同种异体移植排斥主要由受I类同种异体抗原刺激的CD8 + 细胞毒性T淋巴细胞介导,并与识别II类同种异体抗原的CD4 + 辅助性T细胞协同作用。
J Immunol. 1990 Mar 15;144(6):2425-35.
5
Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.转化生长因子-β处理的抗原呈递细胞诱导耐受的机制:CD8调节性T细胞通过涉及Fas配体的机制抑制致敏小鼠免疫反应的效应阶段。
Int Immunol. 2004 May;16(5):697-706. doi: 10.1093/intimm/dxh067. Epub 2004 Mar 29.
6
Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.针对肿瘤相关抗原(TAA)的辅助性T细胞:优先诱导参与抗TAA细胞毒性T淋巴细胞和抗体反应的辅助性T细胞活性。
J Immunol. 1986 Apr 1;136(7):2715-9.
7
Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.转化生长因子-β 对抗原特异性 CD8+ 记忆性 T 细胞扩增的克隆性限制
J Leukoc Biol. 2006 May;79(5):1033-42. doi: 10.1189/jlb.0805474. Epub 2006 Feb 14.
8
Generation of lymphokine-activated killer activity in T cells. Possible regulatory circuits.T细胞中淋巴因子激活的杀伤活性的产生。可能的调节回路。
J Immunol. 1991 May 15;146(10):3280-8.
9
CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hosts.在荷瘤宿主中,CD4 + T细胞能够通过抑制肿瘤特异性CD8 + T细胞反应来促进肿瘤生长。
Cancer Res. 2005 Aug 1;65(15):6984-9. doi: 10.1158/0008-5472.CAN-04-3344.
10
Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.非抗原特异性CD8 + T抑制淋巴细胞起源于CD8 + CD28 - T细胞,并抑制T细胞增殖和CTL功能。
Hum Immunol. 2004 Feb;65(2):142-56. doi: 10.1016/j.humimm.2003.12.001.

引用本文的文献

1
YAP1/MMP7/CXCL16 axis affects efficacy of neoadjuvant chemotherapy via tumor environment immunosuppression in triple-negative breast cancer.YAP1/MMP7/CXCL16轴通过三阴性乳腺癌肿瘤环境免疫抑制影响新辅助化疗疗效。
Gland Surg. 2021 Sep;10(9):2799-2814. doi: 10.21037/gs-21-612.
2
Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer.转移性乳腺癌的局部放射治疗和系统 TGFβ 阻断。
Clin Cancer Res. 2018 Jun 1;24(11):2493-2504. doi: 10.1158/1078-0432.CCR-17-3322. Epub 2018 Feb 23.
3
Effect of non-alcoholic liver disease on recurrence rate and liver regeneration after liver resection for colorectal liver metastases.
非酒精性肝病对结直肠癌肝转移肝切除术后复发率和肝再生的影响。
Curr Oncol. 2017 Jun;24(3):e233-e243. doi: 10.3747/co.24.3133. Epub 2017 Jun 27.
4
Effect of nutrient starvation on proliferation and cytokine secretion of peripheral blood lymphocytes.营养饥饿对外周血淋巴细胞增殖及细胞因子分泌的影响。
Mol Clin Oncol. 2016 Apr;4(4):607-610. doi: 10.3892/mco.2016.763. Epub 2016 Feb 3.
5
Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist.社区肿瘤学家的嵌合抗原受体T细胞疗法
Oncologist. 2016 May;21(5):608-17. doi: 10.1634/theoncologist.2015-0421. Epub 2016 Mar 23.
6
Scutellaria extract and wogonin inhibit tumor-mediated induction of T(reg) cells via inhibition of TGF-β1 activity.黄芩提取物和汉黄芩素通过抑制 TGF-β1 活性抑制肿瘤介导的 T(reg)细胞诱导。
Cancer Immunol Immunother. 2012 May;61(5):701-11. doi: 10.1007/s00262-011-1130-3. Epub 2011 Nov 6.
7
Immunotherapy for head and neck cancer: advances and deficiencies.头颈部癌症的免疫治疗:进展与不足。
Anticancer Drugs. 2011 Aug;22(7):674-81. doi: 10.1097/CAD.0b013e328340fd18.
8
Adiponectin receptors are downregulated in human gastric cancer.脂联素受体在人胃癌中下调。
J Gastroenterol. 2010 Sep;45(9):918-27. doi: 10.1007/s00535-010-0228-2. Epub 2010 Mar 25.
9
Cancer vaccine development: designing tumor cells for greater immunogenicity.癌症疫苗的开发:设计更具免疫原性的肿瘤细胞。
Front Biosci (Landmark Ed). 2010 Jan 1;15(1):309-20. doi: 10.2741/3622.
10
Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.趋化因子受体在癌症转移中的作用以及癌细胞衍生趋化因子在宿主免疫反应中的作用。
Cancer Sci. 2007 Nov;98(11):1652-8. doi: 10.1111/j.1349-7006.2007.00606.x.